Fermenta Biotech Limited (Fermenta), a pioneer in pharmaceutical and nutritional ingredients; one of the world's leading manufacturers of Vitamin D3, has received the Certificate of Suitability (CEP) by the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its spray-dried variant, Vitadee 100 SD – Cholecalciferol Concentrate (Powder Form) 100, 000 IU/g being manufactured at its Kullu, Himanchal Pradesh facility.

Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3. The approval underscores Fermenta's adherence to the stringent European Pharmacopoeial Standards for manufacturing and product quality.

Commenting on the achievement, Prashant Nagre, Managing Director of Fermenta, shared: "As we enter our 75th year, receiving the CEP for VITADEE™ 100 SD marks a significant milestone for Fermenta. It reinforces our commitment to the benchmarks of regulatory compliance by growing our product portfolio whilst strengthening our position as an established global partner in the field of Vitamin D3. This accreditation also enables us to move further up the value chain and stands as yet another testament to our focus on excellence, innovation, and trust."